Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient preference crossover study of oral immediate-release versus transdermal oxybutynin in overactive bladder
2006-000475-16Phase 4Terminated
- Sponsor
- Department of Urology, University Medical Center Mainz
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oxybutynin in overactive bladder (OAB) (2 arms), sponsored by Department of Urology, University Medical Center Mainz. Primary endpoints: Treatment preference, End-of-period satisfaction rating and 1 more. Started May 2007; status: terminated.
02
Drugs
oxybutynin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on 2006-000475-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000475-16.